Navigation Links
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
Date:4/29/2009

Claims to Cover Therapeutic Delivery Across Blood-Brain Barrier

NOVATO, Calif., April 29 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced that the United States Patent and Trademark Office ("USPTO") has issued two Notices of Allowance for U.S. Patent Application Nos. 10/812,849 and 11/202,566, titled "Methods of increasing delivery of active agents to brain comprising administering receptor-associated protein ("RAP") fragments conjugated to active agents."

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO)

The newly allowed claims relate to Raptor's NeuroTrans(TM) platform and generally cover the use of its proprietary RAP peptides in the delivery of diagnostic and therapeutic agents across the BBB into the central nervous system ("CNS"). The claims broadly encompass all neurological disorders, including Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Multiple Sclerosis, and Amytrophic Lateral Sclerosis. We expect the official patents to issue in 2009, and if they do, will have a preliminary patent term that expires in 2023.

NeuroTrans(TM) has been designed to deliver drugs across the BBB in a minimally invasive way by conjugating them to RAP peptides engineered by Raptor. Hundreds of neurodegenerative disorders are ineffectively treated because most drugs are unable to penetrate the BBB and deliver a therapeutic effect. The development of effective brain targeting and delivery technologies, such as NeuroTrans(TM), has the potential to address the challenges involved in treating many of these CNS disorders.

Christopher M. Starr, Ph.D., Raptor's Chief Executive Officer and Co-Founder, commented, "We are pleased that the USPTO has allowed pivotal claims that may offer strong
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sony Biotechnology Inc. ("Sony") today announced the launch of ... be exhibiting and taking orders for this system at ... San Diego Convention Center in ... - 22.  The SP6800 Spectral Analyzer ... into new and novel functionalities for the immunology, oncology, ...
(Date:5/17/2013)... FARMINGTON, Conn. , May 17, 2013 /PRNewswire-iReach/ ... antibodies and recombinant proteins, is placing renewed emphasis ... on the rise as a number of factors ... opportunity for pharmaceutical makers and their delivery device ... for previously refractory conditions, the growing trend toward ...
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3
... Roxane Laboratories, Inc. announced today the approval of ... Potassium Tablets USP, 25mg, 50mg and 100mg as ... and 100mg/25mg by the U.S. Food and Drug ... to wholesalers and pharmacies nationwide. Roxane ...
... DiFUSION Technologies Inc., a medical device company ... proprietary CleanFUZE™ anti-microbial technology for orthopedic implants, announced ... line of posterior interbody devices indicated for intervertebral ... to SI, in skeletally mature patients who have ...
Cached Medicine Technology:Roxane Laboratories, Inc. Announces the Launch of Losartan Potassium Tablets USP and Losartan Potassium and Hydrochlorothiazide Tablets 2DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion 2
(Date:5/18/2013)... FL (PRWEB) May 18, 2013 The ... to the special places we call home. These are the ... maps. They are the locations where the people are friendly ... show takes viewers off the highways and shares the best ... of both nations with an American sports and film celebrity. ...
(Date:5/18/2013)... Family Magazine of Washington DC was awarded the "Best ... Inc. in the category of Summer Camps in DC ... the areas best in the ultimate guide on parenting, kids ... Brenda Hyde, a mother of four and publisher of Family ... vast resources available to them in the DC Metro area. ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices ... Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user ... studies the major market drivers, restraints, and opportunities in ... , Browse , 147 market ... , 318 pagesand in-depth TOC of ...
(Date:5/18/2013)... Francisco, CA (PRWEB) May 18, 2013 ... appointments for 2013 therapies. At the Ayurvedic Spa ... guidance of panchakarma practitioner and lifestyle recommendations ... Ayurveda, the “knowledge of life", is the traditional healthcare ... that a life of harmony is the basis for ...
(Date:5/18/2013)... Stow, Ohio (PRWEB) May 18, 2013 ... 40th Annual Conference, on May 17-22 in Austin, ... associates gather for educational and networking opportunities. ... cleaning brushes, flexible scope repair capabilities ... presented with valuable educational information on proper instrument ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... Agency advises against everything but jars of peanut butter ... Keebler peanut butter cookies; toll at 453 sickened, 6 ... 17 (HealthDay News) -- The U.S. Food and Drug ... butter products containing peanut butter or peanut butter paste, ...
... peanut butter cookies; FDA asks more companies to test ... sick in 43 states and 1 in Canada, and ... -- Cereal giant Kellogg recalled 16 products containing peanut ... investigation into peanut products possibly contaminated with salmonella. , ...
... chance to win up to $2,500 and promote colon-cancer ... Hutchinson Cancer Research Center,s "Get Screened" video contest - ... the importance of colorectal-cancer screening - has been extended ... Center,s ongoing awareness campaign - "Your colon. Your ...
... Jan. 16 Crdentia Corporation (the "Company") today has ... the Company,s non-reporting status. In conjunction with this, ... conjunction with its transfer agent, Computershare. All share ... listed below for reissuance of new share certificates, although ...
... ARLINGTON, Va., Jan. 16 Despite growing numbers on the ... involved in fatal collisions during 1997-2006 than in years past, ... deaths among drivers 70 and older fell 21 percent during ... of people 70 and older rose 10 percent. Compared with ...
... KJT Group announces a former Harris Interactive executive has joined ... pleased to announce the appointment of J. Scott Moller, M.S. ... Rochester, Mr. Moller has a BA in Economics and Political ... Analysis from the University of Rochester . Before ...
Cached Medicine News:Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 2Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 3Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 4Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4Health News:'Get Screened' Video Contest Deadline Extended to Jan. 30 2Health News:Crdentia Corp. Finalizes Reverse Stock Split 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 3Health News:KJT Group L.L.C. Continues Solid Growth 2
... holds up to eight probe array cartridge ... rotate for controlled hybridization of up to ... temperature control for consistent performance across all ... is available in both 110V and 220V ...
Inquire...
... (WxDxH): 31.1 x 13.6 x 15.3 cm, ... x 20.5 cm, Capacity: 4 - 50 ... 35 mm bottles, 4 - 150 x ... x 80 mm bottle, Power Requirements: 100/120V ...
... Minifold I system consists of four basic components: ... and metal clamping plate (see diagram). The sample ... producing spots, dots, or slots (see below). All ... as an accessory plate in conjunction with a ...
Medicine Products: